Cargando…

A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation

BACKGROUND: Artificial intelligence (AI) algorithms are capable of automatically detecting contouring boundaries in medical images. However, the algorithms impact on clinical practice of cervical cancer are unclear. We aimed to develop an AI-assisted system for automatic contouring of the clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Shihong, Wei, Yuanfeng, Zhao, Fen, Dong, Ya, Chen, Yan, Li, Qiaoqi, Du, Wei, Li, Xin, Yang, Xi, Li, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667653/
https://www.ncbi.nlm.nih.gov/pubmed/36380378
http://dx.doi.org/10.1186/s13014-022-02157-5
_version_ 1784831764486684672
author Nie, Shihong
Wei, Yuanfeng
Zhao, Fen
Dong, Ya
Chen, Yan
Li, Qiaoqi
Du, Wei
Li, Xin
Yang, Xi
Li, Zhiping
author_facet Nie, Shihong
Wei, Yuanfeng
Zhao, Fen
Dong, Ya
Chen, Yan
Li, Qiaoqi
Du, Wei
Li, Xin
Yang, Xi
Li, Zhiping
author_sort Nie, Shihong
collection PubMed
description BACKGROUND: Artificial intelligence (AI) algorithms are capable of automatically detecting contouring boundaries in medical images. However, the algorithms impact on clinical practice of cervical cancer are unclear. We aimed to develop an AI-assisted system for automatic contouring of the clinical target volume (CTV) and organs-at-risk (OARs) in cervical cancer radiotherapy and conduct clinical-based observations. METHODS: We first retrospectively collected data of 203 patients with cervical cancer from West China Hospital. The proposed method named as SegNet was developed and trained with different data groups. Quantitative metrics and clinical-based grading were used to evaluate differences between several groups of automatic contours. Then, 20 additional cases were conducted to compare the workload and quality of AI-assisted contours with manual delineation from scratch. RESULTS: For automatic CTVs, the dice similarity coefficient (DSC) values of the SegNet trained with incorporating multi-group data achieved 0.85 ± 0.02, which was statistically better than the DSC values of SegNet independently trained with the SegNet((A)) (0.82 ± 0.04), SegNet((B)) (0.82 ± 0.03) or SegNet((C)) (0.81 ± 0.04). Moreover, the DSC values of the SegNet and UNet, respectively, 0.85 and 0.82 for the CTV (P < 0.001), 0.93 and 0.92 for the bladder (P = 0.44), 0.84 and 0.81 for the rectum (P = 0.02), 0.89 and 0.84 for the bowel bag (P < 0.001), 0.93 and 0.92 for the right femoral head (P = 0.17), and 0.92 and 0.91 for the left femoral head (P = 0.25). The clinical-based grading also showed that SegNet trained with multi-group data obtained better performance of 352/360 relative to it trained with the SegNet((A)) (334/360), SegNet((B)) (333/360) or SegNet((C)) (320/360). The manual revision time for automatic CTVs (OARs not yet include) was 9.54 ± 2.42 min relative to fully manual delineation with 30.95 ± 15.24 min. CONCLUSION: The proposed SegNet can improve the performance at automatic delineation for cervical cancer radiotherapy by incorporating multi-group data. It is clinically applicable that the AI-assisted system can shorten manual delineation time at no expense of quality. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13014-022-02157-5.
format Online
Article
Text
id pubmed-9667653
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96676532022-11-17 A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation Nie, Shihong Wei, Yuanfeng Zhao, Fen Dong, Ya Chen, Yan Li, Qiaoqi Du, Wei Li, Xin Yang, Xi Li, Zhiping Radiat Oncol Research BACKGROUND: Artificial intelligence (AI) algorithms are capable of automatically detecting contouring boundaries in medical images. However, the algorithms impact on clinical practice of cervical cancer are unclear. We aimed to develop an AI-assisted system for automatic contouring of the clinical target volume (CTV) and organs-at-risk (OARs) in cervical cancer radiotherapy and conduct clinical-based observations. METHODS: We first retrospectively collected data of 203 patients with cervical cancer from West China Hospital. The proposed method named as SegNet was developed and trained with different data groups. Quantitative metrics and clinical-based grading were used to evaluate differences between several groups of automatic contours. Then, 20 additional cases were conducted to compare the workload and quality of AI-assisted contours with manual delineation from scratch. RESULTS: For automatic CTVs, the dice similarity coefficient (DSC) values of the SegNet trained with incorporating multi-group data achieved 0.85 ± 0.02, which was statistically better than the DSC values of SegNet independently trained with the SegNet((A)) (0.82 ± 0.04), SegNet((B)) (0.82 ± 0.03) or SegNet((C)) (0.81 ± 0.04). Moreover, the DSC values of the SegNet and UNet, respectively, 0.85 and 0.82 for the CTV (P < 0.001), 0.93 and 0.92 for the bladder (P = 0.44), 0.84 and 0.81 for the rectum (P = 0.02), 0.89 and 0.84 for the bowel bag (P < 0.001), 0.93 and 0.92 for the right femoral head (P = 0.17), and 0.92 and 0.91 for the left femoral head (P = 0.25). The clinical-based grading also showed that SegNet trained with multi-group data obtained better performance of 352/360 relative to it trained with the SegNet((A)) (334/360), SegNet((B)) (333/360) or SegNet((C)) (320/360). The manual revision time for automatic CTVs (OARs not yet include) was 9.54 ± 2.42 min relative to fully manual delineation with 30.95 ± 15.24 min. CONCLUSION: The proposed SegNet can improve the performance at automatic delineation for cervical cancer radiotherapy by incorporating multi-group data. It is clinically applicable that the AI-assisted system can shorten manual delineation time at no expense of quality. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13014-022-02157-5. BioMed Central 2022-11-15 /pmc/articles/PMC9667653/ /pubmed/36380378 http://dx.doi.org/10.1186/s13014-022-02157-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Nie, Shihong
Wei, Yuanfeng
Zhao, Fen
Dong, Ya
Chen, Yan
Li, Qiaoqi
Du, Wei
Li, Xin
Yang, Xi
Li, Zhiping
A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation
title A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation
title_full A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation
title_fullStr A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation
title_full_unstemmed A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation
title_short A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation
title_sort dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667653/
https://www.ncbi.nlm.nih.gov/pubmed/36380378
http://dx.doi.org/10.1186/s13014-022-02157-5
work_keys_str_mv AT nieshihong adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT weiyuanfeng adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT zhaofen adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT dongya adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT chenyan adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT liqiaoqi adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT duwei adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT lixin adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT yangxi adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT lizhiping adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT nieshihong dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT weiyuanfeng dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT zhaofen dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT dongya dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT chenyan dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT liqiaoqi dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT duwei dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT lixin dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT yangxi dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation
AT lizhiping dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation